Bellido V, le Roux CW, Ekinci EI et al. · Lancet (London, England) · PMID 42810372
From the original abstract
“Treatment with retatrutide resulted in substantial improvements in bodyweight and was associated with improvements in glycaemic control in participants with obesity and type 2 diabetes,…”
From the abstract’s interpretation section. This is a shortened quotation; the full sentence continues in the original abstract.
Read the full abstract & conclusionCheck the methods for the exact molecule, preparation, and research model. Measurements of a naturally occurring peptide differ from testing its administration. Cell and animal findings need separate evaluation in people.
A brief excerpt cannot capture the complete methods, results, adverse events, or limitations. Check the full abstract and original paper before interpreting the finding.
Educational research information. A publication does not verify the identity, quality, or safety of products sold here.
Back to Retatrutide studies